Eight of the 23 genes in our resistant signature displayed average expression in tumor samples greater than 2-fold normal controls (CDH6, IRF6, MXRA5, WNT7A, MUC16, MAL2, ZBED2 and S100A14) (Figure 5A & Supplementary Table 6). Here, IRF6 is linked to neoplasm.